Clinical trial Recruiting at 15 sites Observational Ages 13 to 14

Long-term outcomes of adolescents with esophageal atresia

Official title: Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence

Run by University Hospital, Lille · NCT05995171 · Data updated 2026-11-12

This study is trying to learn about the long-term health of teenagers who were born with esophageal atresia by collecting medical data and samples to see how they are doing after their surgeries.

More Esophageal Atresia trials

Quick facts

Study typeObservational
Ages13 Years to 14 Years
SexAll
Enrollment300 (estimated)
SponsorUniversity Hospital, Lille
Academic / other
Locations33 sites (Lille, Nord and 32 other locations)
StatusRecruiting
StartedNovember 14, 2023
Main results expectedNovember 14, 2026
Study endsNovember 14, 2026
Registry record updatedApril 22, 2026
Trial IDNCT05995171 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents aged 13 or 14 who were born with esophageal atresia and have undergone the necessary surgical procedures.

Probably not a fit

Patients with chronic progressive diseases or those who do not meet the inclusion criteria for the study may not receive any benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a prospective cohort of adolescents aged 13 and 14 who were born with esophageal atresia in France. It will involve collecting clinical and omic data, including a biobank of esophageal mucosa and plasma blood samples, to assess the long-term outcomes of this rare condition. The data will be analyzed using the France Cohortes information system to establish multi-omic profiles and understand the health issues that persist after surgical intervention.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term health challenges faced by adolescents with esophageal atresia, potentially leading to improved management strategies.

How similar studies have gone: While there may be studies on esophageal atresia, this approach of creating a multi-omic profile in adolescents is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For the oesophageal atresia group :
* Born with oesophageal atresia (EA) in France or in French overseas departments and territories
* Anastomosis performed
* Included into the ReNaTo registry
* Aged 13 or 14 during the recruitment period
* Patient willing to comply with all study procedures and duration
* Patient will social security

For the blood sub-study :

* Upper GI endoscopy performed as part of care between 13 and 14 years of age with esophageal mucosal biopsy sampling
* Patient having given written consent to participate in the study

For the control arm:

* Upper GI endoscopy performed as part of care between 10 and 14 years of age with oesophageal mucosal biopsy sampling
* Upper GI endoscopy performed as part of care for chronic or acute digestive signs to rule out organic etiology (peptic esophagitis, gastric esophagitis, eosinophilic esophagitis or ulcer)
* Normal endoscopy and histology
* No chronic progressive disease

Exclusion Criteria:

* For the oesophagal atresia arm :
* Concurrent participation in an interventional trial and in the 3 months prior to inclusion
* Parents refusing to participate in the study

For the control arm :

* Histologically non-normal esophageal biopsy
* Parents refusing to participate in the study
* Child with known organic pathology

Where it's running

  • CHU de Lille Hôpital Jeanne de Flandre
    Lille, Nord, France
    Recruiting
  • CHU Angers
    Angers, France
    Recruiting
  • CHU Bordeaux
    Bordeaux, France
    Recruiting
  • HLC Hôpital Mère Enfant
    Bron, France
    Recruiting
  • CHU Caen
    Caen, France
    Recruiting
  • CHI Créteil
    Créteil, France
    Recruiting
Show 27 more locations
  • CHU Dijon
    Dijon, France
    Recruiting
  • AP-HM Hôpital La Timone
    Marseille, France
    Recruiting
  • CHU Montpellier
    Montpellier, France
    Recruiting
  • CHU Nantes
    Nantes, France
    Recruiting
  • AP-HP Hôpital Necker
    Paris, France
    Recruiting
  • AP-HP Hôpital Robert Debré
    Paris, France
    Recruiting
  • CHU Poitiers
    Poitiers, France
    Recruiting
  • CHU de Rennes
    Rennes, France
    Recruiting
  • CHU Fort de France
    Fort-de-France, Martinique
    Recruiting
  • CHU Amiens
    Amiens, France
    Not yet recruiting
  • CHU Besançon
    Besançon, France
    Not yet recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, France
    Not yet recruiting
  • CHU Grenoble
    La Tronche, France
    Not yet recruiting
  • AP-HP Hôpital Kremlin Bicêtre
    Le Kremlin-Bicêtre, France
    Not yet recruiting
  • CHU Le Mans
    Le Mans, France
    Not yet recruiting
  • CHU Limoges
    Limoges, France
    Not yet recruiting
  • CHU Nancy Hôpital Brabois
    Nancy, France
    Not yet recruiting
  • CHU Nice
    Nice, France
    Not yet recruiting
  • CHU Orléans
    Orléans, France
    Not yet recruiting
  • AP-HP Hôpital Armand Trousseau
    Paris, France
    Not yet recruiting
  • CHU de Reims
    Reims, France
    Not yet recruiting
  • CHU Rouen
    Rouen, France
    Not yet recruiting
  • CHU Saint Etienne
    Saint-Etienne, France
    Not yet recruiting
  • CHU Strasbourg
    Strasbourg, France
    Not yet recruiting
  • CHU Toulouse
    Toulouse, France
    Not yet recruiting
  • CHU Tours
    Tours, France
    Not yet recruiting
  • CHU de Saint Denis de la Réunion
    Saint-Denis, Reunion
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.